Answers are grounded in this paper and cite their sources.
Loading...
Evaluates immune responses in cats inoculated with feline leukemia virus, indicating significant immunosuppression.
Summary Cellular and humoral immune capabilities were evaluated in 18 cats inoculated at birth with feline leukemia virus and in 16 age-matched control cats. The assays were performed at 2-week intervals between 5 and 19 weeks of age. All control cats rejected cutaneous allografts at 13.1±1.4 days. Sixteen of eighteen FeLV-infected cats (89%) had significantly (P<0.01) longer allograft retention times (≧18 days). These differences were first noted in 5-week-old cats. Humoral antibody responsiveness (measured by hemagglutination titers to sheep red blood cells) was not significantly altered during leukemogenesis. Marked thymic atrophy appeared in the infected cats as early as 5 weeks of age, and persisted into the neoplastic period (19 weeks of age). These results indicate that significant depression of cell-mediated immunity occurs in the preneoplastic phase of experimental feline lymphosarcoma, and that thymic atrophy is a preleukemic lesion.
Perryman et al. (1972) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: